Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1741 to 1755 of 2186 results for guidelines

  1. Atrial fibrillation: The management of atrial fibrillation (CG36)

    This guidance has been updated and replaced by NICE guideline CG180.

    Withdrawn guideline

  2. Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care (CG38)

    This guidance has been updated and replaced by NICE guideline CG185.

    Withdrawn guideline

  3. Type 2 diabetes (CG66)

    This guidance has been updated and replaced by NICE guideline NG28.

    Withdrawn guideline

  4. Pressure ulcer prevention: pressure ulcer risk assessment and prevention, including the use of pressure-relieving devices (beds, mattresses and overlays) for the prevention of pressure ulcers in primary and secondary care (CG7)

    This guidance has been updated and replaced by NICE guideline CG179.

    Withdrawn guideline

  5. Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care (CG73)

    This guidance has been updated and replaced by NICE guideline CG182.

    Withdrawn guideline

  6. Rheumatoid arthritis in adults: management (CG79)

    This guidance has been updated and replaced by NICE guideline NG100.

    Withdrawn guideline

  7. Dyspepsia: Management of dyspepsia in adults in primary care (CG17)

    This guidance has been updated and replaced by NICE guideline CG184.

    Withdrawn guideline

  8. Osteoarthritis: care and management (CG177)

    This guidance has been updated and replaced by NICE guideline NG226.

    Withdrawn guideline

  9. Atrial fibrillation: management (CG180)

    This guidance has been updated and replaced by NICE guideline NG196.

    Withdrawn guideline

  10. Multiple sclerosis in adults: management (CG186)

    This guidance has been updated and replaced by NICE guideline NG220.

    Withdrawn guideline

  11. Endovascular stent–grafts for the treatment of abdominal aortic aneurysms (TA167)

    This guidance has been updated and replaced by NICE guideline NG156.

    Withdrawn guidance

  12. Guidance on the use of capecitabine for the treatment of locally advanced or metastatic breast cancer (TA62)

    This appraisal has been updated and replaced by NICE guideline CG81.

    Withdrawn guidance

  13. Guidance on the use of photodynamic therapy for age-related macular degeneration (TA68)

    This guidance has been updated and replaced by NICE guideline NG82.

    Withdrawn guidance

  14. Exenatide prolonged-release suspension for injection in combination with oral antidiabetic therapy for the treatment of type 2 diabetes (TA248)

    This guidance has been updated and replaced by NICE guideline NG28.

    Withdrawn guidance

  15. Liraglutide for the treatment of type 2 diabetes mellitus (TA203)

    This guidance has been updated and replaced by NICE guideline NG28.

    Withdrawn guidance